Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 19/20 | 0.72 |
| ▸ | BCL2 | P10415 | 14/20 | 0.68 |
| ▸ | BCL2L2 | Q92843 | 6/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.62 |
| ▸ | ALB | P02768 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3819345 | 1.00 | BCL2L1 (0.72) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL555323 | 1.00 | BCL2L1 (0.72) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL555322 | 1.00 | BCL2L1 (0.72) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL25422833 | 0.97 | BCL2L1 (0.68) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL25422835 | 0.97 | BCL2L1 (0.68) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL3819283 | 0.93 | BCL2L1 (0.70) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL31570886 | 0.93 | BCL2L1 (0.70) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL4747130 | 0.92 | BCL2L1 (0.69) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL3822342 | 0.92 | BCL2L1 (0.69) | BCL2L1BCL2BCL2L2MCL1ALB | |
| SCHEMBL3823004 | 0.92 | BCL2L1 (0.69) | BCL2L1BCL2BCL2L2MCL1ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118084904-A | Benzamide compounds | 里科瑞尔姆IP控股有限责任公司 | 2024-05-28 | — | — | CN | disclosed |
| CN-111801327-B | Benzamide compounds | 里科瑞尔姆IP控股有限责任公司 | 2024-02-09 | — | — | CN | disclosed |
| CN-114126616-A | Nanoparticle formulations of BCL-2 inhibitors | 里科瑞尔姆IP控股有限责任公司 | 2022-03-01 | — | — | CN | disclosed |